EVALUATION OF THE EFFECTIVENESS OF TARGET THERAPY IN THE TREATMENT OF PATIENTS WITH POLYANGIITIS GRANULEMATOSIS
Berdiyeva D.U., Djurayeva E.R., Sultonova M.X., Bekenova G.T., Pulatova SH.B.
Abstract
In recent years, EULAR, ERA-EDTA, European Vasculitis Society, British Society of Rheumatology, British Association of Rheumatologists have recommendations for PAG treatment. Due to the variety of clinical manifestations and the severity of the prognosis, it is always difficult to choose a treatment strategy for patients with PAG. The need for timely diagnosis of PAG is determined by the need for early initiation of aggressive therapy. The main goal of therapy is to suppress the immunopathological reactions underlying the disease in order to achieve complete remission. In this article, we can witness the evaluation of the effectiveness of target therapy in the treatment of polyangiitis granulomatosis.
Keywords:
:granulomatosis with polyangiitis, treatment.Full Text:
PDFReferences
1. Berdieva D.U., Djuraeva E.R. Clinical case of Granulematosis Vegenera v sochetanii s sakharnym diabetes // "Vestnik TMA" - 2018. - №2. - S.138-140.
2. Berdieva D.U., Rizamukhamedova M.Z., Djuraeva E.R., Tashpulatova M.M. Features of the course of Wegener's granulomatosis in combination with comorbid pathology // American Journal of Research. – 2018. - #9-10. - P.86-90.
3. Berdieva D.U., Rizamukhamedova M.Z., Nabiyeva D.A., Dzhurayeva E.R., Mukhammadieva S.M., Abduazizova N.H. Granulomatosis with Polyangiitis: Diagnostic Difficulties and Treatment // International Journal of Pharmaceutical Research. - 2020. - Vol. 12(2). - P.745-752.
4. Berdieva D.U., Dzhurayeva E.R., Nabiyeva D.A., Tashpulatova M.M., Sultanova M.H., Nazarova K.H. Difficulties Of Differential Diagnosis Of Granulomatosis With Polyangiitis And Extranodal NK / T-Cell Lymphoma // Chinese journal of industrial hygiene and occupational diseases. - 2021. - Vol. 39. No. 7. – P.329-334.
5. Berdieva D.U. Assessment of clinical and diagnostic indicators of granulomatosis with polyangiitis // British Medical Journal. - 2021. - Vol. 1. No. 2. – P.238-249.
6. Berdieva D.U., Rizamukhamedova M.Z. Complexity of differential diagnostics of extranodal NK/T-cell lymphoma of the nasal type, protekavshey pod maskoy granulomatosis with polyangiitis // "Vestnik TMA" - 2022. - №2. - S.153-156.
7. Berdiyeva D.U., Rizamukhamedova M.Z., Rakhimov S.S. Clinical course of granulomatosis with polyangiitis and diagnostic difficulties // "Vestnik TMA" - 2022. - #2. - S.153-156.
8. Berdieva D.U., Rizamukhamedova M.Z., Djuraeva E.R., Umarova G.K. Effectiveness of anti-V-cell therapy in Wegener's disease // Bulletin of the Tashkent Medical Academy - Proceedings of the 2nd Congress of Rheumatologists of Uzbekistan. - 2018. - S.90-92.
9. Berdieva D.U., Djumaniyozov D.I., Aripova N.A., Nabiev J.M. Evaluation of the effectiveness of the preparation of rituximab in Vegenera disease // All-Russian congress "Botkinskie chteniya" St. Petersburg. - 2021. - S.83-84.
10. Berdieva D.U., Aripova N.A., Djuraeva E.R., Nurmukhammedova N.S., Rakhimov S.S. Evaluation of the effectiveness of the application of anti-B-cell therapy in ganulematosis with polyangiitis // Uzbekiston terapiya information. – 2021. #3. - S.117
11. Berdieva D.U., Rizamukhamedova M.Z., Djuraeva E.R., Sedenkov A. Granulematosis and polyangiitis: diagnosis of pregnancy and leukemia // Uzbekiston therapy information. – 2021. #3. - S.124
12. Berdieva D.U., Ziyaeva F.K., Rakhimov S.S. Osobennosti klinicheskogo techenia razlichnykh variantov grunulematoza s polyangiitom // Tezisov i dokladov mejdunarodnoy nauchno-prakticheskoy konferentsii "Covremennaya rheumatologiya: novye podkhody k diagnostike i lecheniyu". 2022. -S.13-15
13. Berdieva D.U., Rizamukhamedova M.Z., Akhmedov A. Evaluation of morphofunctional and laboratory indicators of granulomatosis with polyangiitis // Tezisov and dokladov mejdunarodnoy nauchno-prakticheskoy konferentsii "Covremennaya rheumatologiya: novye podkhody k diagnostike i lecheniyu". 2022. -S.16-17
14. Groot K. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody–associated vasculitis. A randomized trial / K. Groot [et al.] // Annals of internal medicine. — 2009. — Vol. 150. — № 10. — Р. 670–680.
15. Girard C. Tracheobronchial stenoses in granulomatosis with polyangiitis (Wegener's): a report on 26 cases / C. Girard [et al.] // Medicine (Baltimore). — 2015. — Vol. 94. — № 32. — Р. e1088.
16. Guerry M. Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis / M. Guerry [et al.] // Rheumatology (Oxford). — 2012. — Vol. 51. — № 4. — Р. 634–643.
17. Guillevin L. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort / L. Guillevin [et al.] // Medicine (Baltimore). — 2011. — Vol. 90. — № 1. — Р. 19–27.
18. Guillevin L. et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral, 188 188. Guillevin L, Pagnoux C, Karras A, et al. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. NEJM 2014;371(19):1771-80.
19. Harper L. Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up / L. Harper [et al.] // Annals of the rheumatic diseases. — 2012. — Vol. 71. — № 6. — Р. 955–60.
20. Harper S.L., et al. Wegenerґs granulomatosis: the relationship between ocular and systemic disease J. Rheumatol. 2001. – №28. – P.1025−1026.
21. Hellmich B. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis / B. Hellmich [et al.] // Annals of the rheumatic diseases. — 2007. — Vol. 66. — № 5. — Р. 605–617.
22. Hermann J. Clinical interpretation of antineutrophil cytoplasmic antibodies: parvovirus B19 infection as a pitfall / J. Hermann [et al.] // Annals of the rheumatic diseases. — 2005. — Vol. 64. — № 4. — Р. 641–643.
23. Hernández-Rodríguez J. Surgical Interventions and Local Therapy for Wegener's Granulomatosis / J. Hernández-Rodríguez, G. Hoffman, С. Koening // Current opinion in rheumatology. — 2010. — Vol. 22. — № 1. — Р. 29–36.
24. Hoffman G. S. Wegener granulomatosis: An analysis of 158 patients / G. S. Hoffman [et al.] // Annals of internal medicine. — 1992. — Vol. 116. — № 6. — Р. 488–498.
25. Holle J.U. Prospective long-term follow-up of patients with localised Wegener’s granulomatosis: does it occur as persistent disease stage? vasculitides / J. U. Holle [et al.] // Annals of the rheumatic diseases. — 2010. — Vol. 69. — № 11. — Р. 1934–1939.
26. Holle J.U., Windmöller M., Lange C., Gross W.L., Herlyn K., and Csernok E. Toll-like receptor TLR2 and TLR9 ligation triggers neutrophil activation in granulomatosis with polyangiitis. // Rheumatol. Oxf. Engl. 2013. – P.257-266
27. Holle J.U., Gross W.L., Latza U., Nölle B., Ambrosch P., Heller M., et al. Improved outcome in 445 patients with Wegener’s granulomatosis in a German vasculitis center over four decades. // Arthritis Rheum 2011. – №63. – P.257-66.
28. Holle J.U. Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations / J. U. Holle [et al.] // Annals of the rheumatic diseases. — 2012. — Vol. 71. — № 3. — Р. 327–333.
29. Hu W. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement / W. Hu [et al.] // Nephrology, dialysis, transplantation. — 2008. — Vol. 23. — № 4. — Р. 1307–1312.
30. Hugle B. et al. Pneumocystis jiroveci pneumonia following rituximab treatment in Wegener’s granulomatosis. // Arthritis Care Res. 2010. – №62. – P.1661–1664.
31. IANNELLA G. et al. Granulomatosis with polyangiitis and facial palsy: Literature review and insight in the autoimmune pathogenesis. Autoimmun Rev, v. 15, n. 7, p. 621-31, Jul 2016. ISSN 1873-0183 (Electronic) 1568-9972 (Linking). Available at: < https://www.ncbi.nlm.nih.gov/pubmed/26851550 >
32. Jagiello P. New genomic region for Wegener’s granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes / P. Jagiello [et al.] // Human genetics. — 2004. — Vol. 114. — № 5. — Р. 468–477.
Refbacks
- There are currently no refbacks.
